116 related articles for article (PubMed ID: 10619175)
21. Antagonistic effect of N-methyltyramine on alpha2-adrenoceptor in mice.
Koda H; Yokoo Y; Matsumoto N; Suwa Y; Fukazawa H; Ishida H; Tsuji K; Nukaya H; Kuriyama K
Jpn J Pharmacol; 1999 Nov; 81(3):313-5. PubMed ID: 10622222
[TBL] [Abstract][Full Text] [Related]
22. Antipsychotic drugs induce Fos protein in the thalamic paraventricular nucleus: a novel locus of antipsychotic drug action.
Deutch AY; Ongür D; Duman RS
Neuroscience; 1995 May; 66(2):337-46. PubMed ID: 7477876
[TBL] [Abstract][Full Text] [Related]
23. Haloperidol, but not clozapine, produces dramatic catalepsy in delta9-THC-treated rats: possible clinical implications.
Marchese G; Casti P; Ruiu S; Saba P; Sanna A; Casu G; Pani L
Br J Pharmacol; 2003 Oct; 140(3):520-6. PubMed ID: 12970091
[TBL] [Abstract][Full Text] [Related]
24. Enhanced cortical dopamine output and antipsychotic-like effects of raclopride by alpha2 adrenoceptor blockade.
Hertel P; Fagerquist MV; Svensson TH
Science; 1999 Oct; 286(5437):105-7. PubMed ID: 10506554
[TBL] [Abstract][Full Text] [Related]
25. Clozapine-induced dopamine levels in the rat striatum and nucleus accumbens are not affected by muscarinic antagonism.
Gray AM; Connick JH
Eur J Pharmacol; 1998 Dec; 362(2-3):127-36. PubMed ID: 9874162
[TBL] [Abstract][Full Text] [Related]
26. Loxapine and clozapine decrease serotonin (S2) but do not elevate dopamine (D2) receptor numbers in the rat brain.
Lee T; Tang SW
Psychiatry Res; 1984 Aug; 12(4):277-85. PubMed ID: 6239298
[TBL] [Abstract][Full Text] [Related]
27. Alpha2-adrenoceptor antagonism is neither sufficient nor necessary for the distinctive action of atypical neuroleptics on intracranial self-stimulation in the rat.
Montgomery AM; Grottick AJ; Herberg LJ
Behav Pharmacol; 2003 Jul; 14(4):307-14. PubMed ID: 12838036
[TBL] [Abstract][Full Text] [Related]
28. Clozapine inhibits catalepsy induced by olanzapine and loxapine, but prolongs catalepsy induced by SCH 23390 in rats.
Kalkman HO; Neumann V; Tricklebank MD
Naunyn Schmiedebergs Arch Pharmacol; 1997 Mar; 355(3):361-4. PubMed ID: 9089667
[TBL] [Abstract][Full Text] [Related]
29. Prolonged treatment with haloperidol and clozapine in the rat: differential effects on spontaneous and theophylline-induced motor activity.
Ogren SO; Ferré S; Schwarcz R; Fuxe K
Neurosci Lett; 1997 Aug; 232(1):21-4. PubMed ID: 9292882
[TBL] [Abstract][Full Text] [Related]
30. Blockade of phencyclidine-induced hyperlocomotion by olanzapine, clozapine and serotonin receptor subtype selective antagonists in mice.
Gleason SD; Shannon HE
Psychopharmacology (Berl); 1997 Jan; 129(1):79-84. PubMed ID: 9122367
[TBL] [Abstract][Full Text] [Related]
31. Anticholinergic drugs potentiate dopamine D1 but not D2 antagonists on a conditioned avoidance task in rats.
Iorio LC; Cohen M; Coffin VL
J Pharmacol Exp Ther; 1991 Jul; 258(1):118-23. PubMed ID: 1830098
[TBL] [Abstract][Full Text] [Related]
32. Clozapine, haloperidol, and the D4 antagonist PNU-101387G: in vivo effects on mesocortical, mesolimbic, and nigrostriatal dopamine and serotonin release.
Broderick PA; Piercey MF
J Neural Transm (Vienna); 1998; 105(6-7):749-67. PubMed ID: 9826116
[TBL] [Abstract][Full Text] [Related]
33. Why does clozapine stimulate the motor activity of reserpine-pretreated rats when combined with a dopamine D1 receptor agonist?
Jackson DM; Mohell N; Bengtsson A; Malmberg A
Eur J Pharmacol; 1995 Aug; 282(1-3):137-44. PubMed ID: 7498268
[TBL] [Abstract][Full Text] [Related]
34. The central sympatho-inhibitory effect of 5,6-dihydroxy-2-dimethylaminotetralin (M7) is mediated by alpha 2-adrenoceptors.
Vayssettes-Courchay C; Bouysset F; Laubie M; Verbeuren TJ
Eur J Pharmacol; 1997 Feb; 320(2-3):151-9. PubMed ID: 9059848
[TBL] [Abstract][Full Text] [Related]
35. Effects of medullary alpha2-adrenoceptor blockade in the rat.
Vayssettes-Courchay C; Bouysset F; Cordi A; Laubie M; Verbeuren TJ
Eur J Pharmacol; 2002 Oct; 453(2-3):287-97. PubMed ID: 12398917
[TBL] [Abstract][Full Text] [Related]
36. The effects of antipsychotic drugs on Fos protein expression in the prefrontal cortex: cellular localization and pharmacological characterization.
Deutch AY; Duman RS
Neuroscience; 1996 Jan; 70(2):377-89. PubMed ID: 8848147
[TBL] [Abstract][Full Text] [Related]
37. Selectivity and potency of 2-alkyl analogues of the alpha 2-adrenoceptor antagonist idazoxan (RX 781094) in peripheral systems.
Doxey JC; Roach AG; Strachan DA; Virdee NK
Br J Pharmacol; 1984 Nov; 83(3):713-22. PubMed ID: 6150740
[TBL] [Abstract][Full Text] [Related]
38. Acute cardiovascular effects of the alpha2-adrenoceptor antagonist, idazoxan, in rats: influence of the basal sympathetic tone.
Cheng Y; Planta F; Ladure P; Julien C; Barrès C
J Cardiovasc Pharmacol; 2000 Jan; 35(1):156-63. PubMed ID: 10630747
[TBL] [Abstract][Full Text] [Related]
39. Therapeutic potential of alpha2 adrenoceptor antagonism for antipsychotic-induced extrapyramidal motor disorders.
Imaki J; Mae Y; Shimizu S; Ohno Y
Neurosci Lett; 2009 Apr; 454(2):143-7. PubMed ID: 19429072
[TBL] [Abstract][Full Text] [Related]
40. [5-HT1A/1B receptors, alpha2-adrenoceptors and the post-receptor adenylate cyclase activation in the mice brain are involved in the antidepressant-like action of agmatine].
Jiang XZ; Li YF; Zhang YZ; Chen HX; Li J; Wang NP
Yao Xue Xue Bao; 2008 May; 43(5):467-73. PubMed ID: 18717332
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
